Michael D. Prados

73.1k citations

418 papers · 27.6k indexed · 5 hit papers · h-index 90

Impact in

Genetics top 0.01%
- Glioma Diagnosis and Treatment
Neurology top 0.1%
- Neuroblastoma Research and Treatments

Papers in

Genetics 355
- Glioma Diagnosis and Treatment 354
Neurology 83
- Neuroblastoma Research and Treatments 50

Co-authors: Kathleen R. Lamborn Susan M. Chang Mitchel S. Berger Timothy F. Cloughesy Patrick Y. Wen W.K. Alfred Yung William M. Wara Victor A. Levin
Journals: Neuro-Oncology (78 papers)Journal of Clinical Oncology (68 papers)International Journal of Radiation Oncology*Biology*Physics (52 papers)Journal of Neuro-Oncology (39 papers)Neurosurgery (33 papers)
Partner nations: United States Canada Switzerland

In The Last Decade

Michael D. Prados

409 papers receiving 27.0k citations

Hit Papers

5 papers align trajectories log scale

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study 2015 · 433 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Neuro-Oncology
2009 Journal of Clinical Oncology
2008 Journal of Clinical Oncology
1999 Journal of Clinical Oncology
1999 Journal of Clinical Oncology

Peers

Countries citing papers authored by Michael D. Prados

Since Specialization

Citations

This map shows the geographic impact of Michael D. Prados's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Prados with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Prados more than expected).

Fields of papers citing papers by Michael D. Prados

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Prados. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Prados. The network helps show where Michael D. Prados may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael D. Prados, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael D. Prados Line = papers co-authored together Michael D. Prados links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment ofBRAFV600E-Mutant Pediatric Gliomas in the Pacific Pediatric Neuro-Oncology Consortium Clinical Trial American Journal of Neuroradiology ·Divya Ramakrishnan, Sarah C. Brüningk, Marc von Reppert, Fatima Memon, Nazanin Maleki, Sanjay Aneja, Anahita Fathi Kazerooni, Ali Nabavizadeh, MingDe Lin, Khaled Bousabarah, Annette M. Molinaro, Theodore Nicolaides, Michael D. Prados, Sabine Mueller, Mariam Aboian	2024	1
2	PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma Neuro-Oncology ·Sabine Mueller, Cassie Kline, Schuyler Stoller, S Lundy, Lauren Christopher, Alyssa Reddy, Anu Banerjee, Tabitha Cooney, Shannon Raber, Carly Hoffman, Tracy Luks, Eva Wembacher-Schroeder, Nina Lummel, Yalan Zhang, Erin R. Bonner, Javad Nazarian, Annette M. Molinaro, Michael D. Prados, Javier Villanueva-Meyer, Nalin Gupta	2023	28
3	Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy Clinical Cancer Research ·Eshini Panditharatna, Lindsay Kilburn, Mariam Aboian, Madhuri Kambhampati, Heather Gordish‐Dressman, Suresh N. Magge, Nalin Gupta, John S. Myseros, Eugene Hwang, Cassie Kline, John R. Crawford, Katherine E. Warren, Soonmee Cha, Winnie S. Liang, Michael E. Berens, Roger J. Packer, Adam Resnick, Michael D. Prados, Sabine Mueller, Javad Nazarian	2018	123
4	Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein Clinical Cancer Research ·Courtney A. Crane, Seunggu J. Han, Brian Ahn, Jessica Oehlke, Valerie Kivett, Anne Fedoroff, Nicholas Butowski, Susan M. Chang, Jennifer Clarke, Mitchel S. Berger, Michael W. McDermott, Michael D. Prados, Andrew T. Parsa	2012	150
5	The A/G Allele of Rs16906252 Predicts for MGMT Methylation and Is Selectively Silenced in Premalignant Lesions from Smokers and in Lung Adenocarcinomas Clinical Cancer Research ·Shuguang Leng, Amanda M. Bernauer, Chibo Hong, C. Kieu, Christin M. Yingling, Kristina G. Flores, Mathewos Tessema, Carmen S. Tellez, Randall P. Willink, Elizabeth A. Burki, Maria A. Picchi, Christine A. Stidley, Michael D. Prados, J Costello, Frank D. Gilliland, Richard E. Crowell, Steven A. Belinsky	2011	46
6	Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study Journal of Clinical Oncology ·John de Groot, Kathleen R. Lamborn, Susan M. Chang, Mark R. Gilbert, Timothy F. Cloughesy, Kenneth Aldape, Jun Yao, Edward F. Jackson, Frank S. Lieberman, H. Ian Robins, Minesh P. Mehta, Andrew B. Lassman, Lisa M. DeAngelis, W.K. Alfred Yung, Alice P. Chen, Michael D. Prados, Patrick Y. Wen	2011	168
7	Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept Clinical Cancer Research ·John de Groot, Yuji Piao, Hai T. Tran, Mark R. Gilbert, Hua-Kang Wu, Jun Liu, B. Nebiyou Bekele, Tim Cloughesy, Minesh P. Mehta, H. Ian Robins, Andrew B. Lassman, Lisa M. DeAngelis, Kevin Camphausen, Alice P. Chen, W.K. Alfred Yung, Michael D. Prados, Patrick Y. Wen, John V. Heymach	2011	51
8	Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts Cancer Research ·Karine Michaud, David A. Solomon, Eric K. Oermann, Jung-Sik Kim, Wei-Zhu Zhong, Michael D. Prados, Tomoko Ozawa, C. David James, Todd Waldman	2010	254
9	Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma Journal of Clinical Oncology ·Henry S. Friedman, Michael D. Prados, Patrick Y. Wen, Tom Mikkelsen, David Schiff, Lauren E. Abrey, W.K. Alfred Yung, Nina A. Paleologos, M. Kelly Nicholas, Randy L. Jensen, James J. Vredenburgh, Jane Huang, Maoxia Zheng, Timothy F. Cloughesy Hit paper breakdown →	2009	1855
10	p53 Small-Molecule Inhibitor Enhances Temozolomide Cytotoxic Activity against Intracranial Glioblastoma Xenografts Cancer Research ·Eduard B. Dinca, Kan Lu, Jann N. Sarkaria, Russell O. Pieper, Michael D. Prados, Daphne A. Haas‐Kogan, Scott R. VandenBerg, Mitchel S. Berger, C. David James	2008	42
11	Quality of life in low-grade glioma patients receiving temozolomide Neuro-Oncology ·Raymond Liu, Karla Solheim, Mei‐Yin C. Polley, Kathleen R. Lamborn, Margaretta Page, Anne Fedoroff, Jane Rabbitt, Nicholas Butowski, Michael D. Prados, Susan M. Chang	2008	60
12	Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma Journal of Clinical Oncology ·Christopher E. Pelloski, Karla V. Ballman, Alfred Furth, Li Zhang, E. Lin, Erik P. Sulman, Krishna Bhat, J. Matthew McDonald, W.K. Alfred Yung, Howard Colman, Shiao Y. Woo, Amy B. Heimberger, Dima Suki, Michael D. Prados, Susan M. Chang, Fred G. Barker, Jan C. Buckner, C. David James, Kenneth Aldape	2007	239
13	Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma Journal of Clinical Oncology ·James L. Rubenstein, Jane Fridlyand, Lauren E. Abrey, Arthur Shen, Jon Karch, Endi Wang, Samar Issa, Lloyd E. Damon, Michael D. Prados, Michael McDermott, Joan M. O’Brien, Chris Haqq, Marc Shuman	2007	243
14	Nonsynonymous Coding Single-Nucleotide Polymorphisms Spanning the Genome in Relation to Glioblastoma Survival and Age at Diagnosis Clinical Cancer Research ·Margaret Wrensch, Alex McMillan, John K. Wiencke, Joe Wiemels, Karl T. Kelsey, Joe Patoka, Hywel Jones, Victoria Carlton, Rei Miike, Jennette D. Sison, Michelle Moghadassi, Michael D. Prados	2007	16
15	Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01 Clinical Cancer Research ·Andrew B. Lassman, Michael R. Rossi, Jeffrey R. Razier, Lauren E. Abrey, Frank S. Lieberman, Chelsea N. Grefe, Kathleen R. Lamborn, William Pao, Alan H. Shih, John G. Kuhn, Richard K. Wilson, Norma J. Nowak, John K. Cowell, Lisa M. DeAngelis, Patrick Y. Wen, Mark R. Gilbert, Susan M. Chang, WK Alfred Yung, Michael D. Prados, Eric C. Holland	2005	201
16	Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme Investigational New Drugs ·Susan M. Chang, Patrick Y. Wen, Timothy F. Cloughesy, Harry S. Greenberg, David Schiff, Charles A. Conrad, Karen Fink, H. Ian Robins, Lisa De Angelis, Jeffrey J. Raizer, Kenneth R. Hess, Ken Aldape, Kathleen R. Lamborn, John G. Kuhn, Janet Dancey, Michael D. Prados	2005	308
17	Familial Tumors Syndromes of the Central Nervous system Edward Pan, Michael D. Prados	2003	2
18	A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plustemozolomide: A North American Brain Tumor Consortium study Neuro-Oncology ·S. Clifford Schold, John G. Kuhn, Susan M. Chang, Michael E. Bosik, H. I. Robins, Minesh P. Mehta, Alexander M. Spence, Dorcas Fulton, Karen L. Fink, Michael D. Prados	2000	31
19	Infiltrative astrocytomas of the thalamus Journal of neurosurgery ·Hendrikus G. J. Krouwer, Michael D. Prados	1995	40
20	Treatment of Recurrent Gliomas With Eflornithine JNCI Journal of the National Cancer Institute ·Victor A. Levin, Michael D. Prados, W.K. Alfred Yung, Mary Jo Gleason, Sandra Ictech, Mary Malec	1992	52

About Michael D. Prados

Michael D. Prados is a scholar working on Genetics, Neurology, Cancer Research, Structural Biology and Pulmonary and Respiratory Medicine, having authored 418 papers that have together received 27.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (354 papers), Brain Metastases and Treatment (102 papers), Meningioma and schwannoma management (54 papers), Neuroblastoma Research and Treatments (50 papers), Cancer, Hypoxia, and Metabolism (39 papers), Radiomics and Machine Learning in Medical Imaging (36 papers), Cancer Genomics and Diagnostics (26 papers) and Cancer Treatment and Pharmacology (20 papers). The work is most often cited by research in Genetics (18.8k citations), Neurology (5.2k citations), Cancer Research (4.6k citations), Pulmonary and Respiratory Medicine (7.4k citations) and Radiology, Nuclear Medicine and Imaging (4.4k citations). Michael D. Prados has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Kathleen R. Lamborn, Susan M. Chang, Mitchel S. Berger, Timothy F. Cloughesy, Patrick Y. Wen, W.K. Alfred Yung, William M. Wara, Susan M. Chang, Victor A. Levin and David A. Larson. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Journal of Neuro-Oncology and Neurosurgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact